Are we successfully managing cardiovascular disease in people living with HIV?

Camilla I Hatleberg1, Jens D Lundgren, Lene Ryom

  • 1CHIP (Centre of Excellence for Health, Immunity and Infections), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Insights

Cardiovascular disease (CVD) management in people living with HIV (PLWHIV) requires improved screening and prevention strategies. Current approaches are suboptimal, necessitating further research, especially for HIV-positive women.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a significant concern for people living with HIV (PLWHIV).
  • The etiology of CVD in PLWHIV is complex and multifactorial.
  • Current CVD risk factor management in PLWHIV is suboptimal.

Purpose of the Study:

  • To review recent research on CVD management in PLWHIV.
  • To focus on screening, primary, and secondary prevention strategies.
  • To highlight the need for improved CVD risk factor management.

Main Methods:

  • Literature review of recent studies.
  • Analysis of current screening and prevention guidelines.
  • Identification of gaps in research and clinical practice.

Main Results:

  • Data on CVD screening and prevention in PLWHIV are scarce.
  • Optimal risk screening tools for early/subclinical disease are lacking.
  • PLWHIV are undertreated with preventive medications (statins, aspirin, antihypertensives).
  • Effective lifestyle intervention programs (smoking cessation, physical activity, diet) are absent.
  • HIV-positive women represent a particularly vulnerable subgroup requiring focused attention.

Conclusions:

  • Further research is needed to identify barriers to optimal CVD risk factor management in PLWHIV.
  • Increased focus on CVD prevention strategies for HIV-positive women is crucial.
  • Multifaceted approaches are essential for effective CVD management in PLWHIV.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
408
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
476
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
370
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
750
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
399
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
382